Image

Analyzing Gait Pattern Using Insole-type Gait Analyzer in Patient With Gait Disturbance

Analyzing Gait Pattern Using Insole-type Gait Analyzer in Patient With Gait Disturbance

Recruiting
19 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to explore the usefulness of information from insole-type gait analyzer in adults with subjective gait and balance disorders.

The main questions it aims to answer are:

How useful is an insole-type gait analyzer for collecting gait data from patients with gait disturbances?

Researchers will explore the usefulness of collected data and does not establish a control group.

Participants will:

Participants will conduct survey and perform the Timed up and go test wearing an insole-type gait analyzer.

Description

A screening test is conducted after obtaining consent. The screening test assesses whether participants can walk independently on flat ground, following an inquiry into their baseline symptoms and signs.

Participants will conduct A history survey, a sarcopenia questionnaire, and the International Physical Activity Questionnaire (IPAQ).

Participants will wear insole-type gait analyzer and undergo the Timed Up and Go test.

The measurement values of the accelerometer and pressure sensors recorded in the insole-type gait analyzer will be examined to determine the presence of missing or outlier data. Researchers will explore the data collection frequency and analysis methods to extract clinically significant data.

Eligibility

Inclusion Criteria:

  1. adults aged 19 and over (based on the age on their national ID at the time of consent)
  2. adults complaining subjective gait or balance disorders
  3. individuals who voluntarily agree to participate in the study and sign a consent form

Exclusion Criteria:

  1. individuals unable to walk independently on flat ground for more than 6 minutes
  2. individuals who cannot read ordinary print with glasses due to visual reasons
  3. individuals who cannot understand conversation even with a hearing aid due to auditory reasons
  4. individuals with clinically significant disorders in the cardiovascular, gastrointestinal, respiratory, or endocrine systems
  5. individuals considered clinically unsuitable for the trial by the trial manager or person in charge based on significant medical findings.

Study details
    Gait Disorders
    Neurologic

NCT06442982

Yonsei University

10 June 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.